Skip to main content
SpringerLink
Log in

Current perspectives in the use of monoclonal antibodies for detection and treatment of head and neck tumors

  • Clinical Review
  • Published:
European Archives of Oto-Rhino-Laryngology Aims and scope Submit manuscript

Abstract

Squamous cell carcinomas (SCC) represent the vast majority of all malignant tumors of the head and neck. The development of distant metastases is now more often observed among these tumors than in the past. The department of Otolaryngology-Head and Neck Surgery, Free University Hospital has focussed upon the use of monoclonal antibodies (mAb) for treating SCC metastases. MAb E 48 was selected after it was shown to react strongly to SCC and minimally to normal tissues. In animal models clear tumor visualization and impressive tumor regression occurred when the antibody was linked to a suitable isotope. A diagnostic phase I/II study for the detection of lymph node metastases has entered 51 patients with head and neck cancer. Biodistribution data, acquired from surgical specimens, has shown an average tumor uptake of 30m%/g tumor tissue of the injected dose of mAb E 48. Extrapolation of data from therapeutic animal studies to these findings suggests that radioimmunotherapy can be effective in head and neck cancer patients, notably as adjuvant therapy in patients with a high chance of developing distant metastases.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Ali S, Tiwari RM, Snow GB (1985) False positive and false negative neck nodes. Head Neck Surg 8:78–82

    Google Scholar 

  2. Breitz HB, Weiden PL, Heyden JL vander, Appelbaum JW, Bjorn MJ, Fer MF (1992) Clinical experience with rhenium186 labeled monoclonal antibodies for radioimmunotherapy: results of phase 1 trials. J Nucl Med 33:1099–1109

    Google Scholar 

  3. Chatal JF, Saccavini JC, Thedrez P, Curtet C, Kremer M, Guerreua D (1989) Biodistribution of Indium-11-labeled OC 125 monoclonal antibody intraperitoneally injected into patients operated on for ovarian carcinomas. Cancer Res 49:3087–3094

    Google Scholar 

  4. Cobb LM (1989) Intratumour fators influencing the access of antibody to tumour cells. Cancer Immunol Immunother 28: 235–240

    Google Scholar 

  5. Fentiman IS, Mansel RE (1991) The axilla: not a no-go zone. Lancet 337:221–223

    Google Scholar 

  6. Gerretsen M, Quak JJ, Suh JS, Walsum M van, Meijer CJLM, Snow GB, Dongen GAMS van (1991) Superior localization and imaging of radiolabelled monoclonal antibody E48 F(ab′)2 fragment in xenografts of human squamous carcinoma of the vulva and of the head and neck as compared to monoclonal antibody E 48 IgG. Br J Cancer 63:37–44

    Google Scholar 

  7. Gerretsen M, Schrijvers AHGJ, Walsum M van, Braakhuis BJM, Quak JJ, Meijer CJLM, Snow GB, Dongen GAMS van (1992) Radioimmunotherapy of human head and neck squamous cell carcinoma xenografts with 131I labelled monoclonal antibody E48 IgG. Br J Cancer 66:496–502

    Google Scholar 

  8. Goldenberg DM, Griffiths GL (1992) Radioinununotherapy; arming the missiles. J Nucl Med 33:1110–1112

    Google Scholar 

  9. John E, Thakur ML, DeFuvio J, McDevitt ML, Damjanow I (1993) Rhenium-186-labeled monoclonal antibodies for radioimmunotherapy: preparation and evaluation. J Nucl Med 34:260–267

    Google Scholar 

  10. Kennel SJ, Falcioni R, Wesley JW (1991) Microdistribution of specific rat monoclonal antibodies to mouse tissues and human tumor xenografts. Cancer Res 51: 1529–1536

    Google Scholar 

  11. Leemans CR, Tiwari RM, Van der Waal I, Nauta JJP, Snow GB (1993) Regional lymph node involvement and its significance in the development of distant metases in head and neck cancer. Cancer 71:452–456

    PubMed  Google Scholar 

  12. Najafi A, Alauddin MM, Sosa A, Ma CQ, Chen DCP, Epstein AL (1992) The evaluation of 186Re labeled antibodies using N2S4 chelate in vitro and in vivo using tumour-bearing nude mice. Int J Radiat Appl Instrum [B] 19:205–212

    Google Scholar 

  13. Quak JJ, Balm AJM, Brakkee JGP, Scheper RJ, Haisma H, Braakhuis BJM, Meijer CJLM, Snow GB (1989) Localization and imaging of radiolabeled monoclonal antibody against squamous cell carcinoma of the head and neck in tumour bearing nude mice. Int J Cancer 44:534–538

    Google Scholar 

  14. Quak JJ, Brakkee JGP, Scheper RJ, Snow GB, Balm AJM (1989) A comparative study on the production of monoclonal antibodies to head and neck cancer. In: Wolf GT, Carey TE (eds) Head and neck oncology research. Kugler, Amsterdam pp 95–102

    Google Scholar 

  15. Quak JJ, Balm AJM, Brakkee JGP, Scheper RJ, Meijer CJLM, Snow GB (1990) Production of monoclonal antibodies to squamous cell carcinoma antigens. Arch Otolaryngol Head Neck Surg 116:181–185

    Google Scholar 

  16. Quak JJ, Dongen GAMS van, Gerretsen M, Brakkee JGP, Hayashida DJ, Balm AJM, Snow GB, Meijer CJLM (1990) Production of monoclonal antibody to a squamous cell carcinoma antigen identified as the 17-la antigen. Hybridoma 9: 377–387

    Google Scholar 

  17. Quak JJ, Balm AJM, Dongen GAMS van, Brakkee JGP, Scheper RJ, Snow GB, Meijer CJLM (1990) A 22kDa surface antigen detected by monoclonal antibody E 48 is exclusively expressed in stratified and transitional epithelia.Am J Pathol 136:191–197

    Google Scholar 

  18. Quak JJ, Dongen GAMS van, Brakkee JGP, Davis HD, Scheper RJ, Meijer CJLM, Snow GB (1992) Expression and characterization of two differentiation antigens in stratified squamous epithelia and carcinomas. Int J Cancer 50:507–513

    Google Scholar 

  19. Schrijvers AHGJ, Gerretsen M, Walsum M van, Braakhuis BJM, Quak JJ, Snow GB, Dongen GAMS van (1991) Evidence for a role of the monoclonal antibody E48 defined antigen in cell adhesion in squamous epithelia. Exp Cell Res 196:264–269

    Google Scholar 

  20. Schrijvers AHGJ, Gerretsen M, Walsum M van, Braakhuis BJM, Quak JJ, Snow GB, Dongen GAMS van (1992) Potential for targeting head and neck squamous cell carcinoma with monoclonal antibody K984. Cancer Immunol Immunother 34: 252–258

    Google Scholar 

  21. Schrijvers AHJG, Quak JJ, Uyterlinde AM, Walsum M van, Meijer CJLM, Snow GB, Dongen GAMS van (1993) Mab U 36, a novel monoclonal antibody successful in immunotargeting squamous cell carcinoma of the head and neck. Cancer Res 53:4383–4390

    Google Scholar 

  22. Shikani AH, Richtsmeijer WJ, Klein JL, Kopher KA (1992) Radiolabeled antibody therapy for squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg 118: 521–525

    Google Scholar 

  23. Snow GB (1989) Evaluation of new treatment methods for head and neck cancer: a challenge. Acta Otolaryngol (Stockh) 107:352–356

    Google Scholar 

  24. Van den Brekel MWM, Stel HV, Castelijns JA, Nauta JJP, Waal I van der, Valk J, Meijer CJLM, Snow GB (1990) Cervical lymph node metastasis: assessment of radiologic criteria. Radiology 177:379–384

    Google Scholar 

  25. Van den Brekel MWM, Castelijns JA, Stel HV, Valk J, Snow GB (1990) Detection and characterization of metastatic cervical adenopathy by MRI imaging, comparison of different MR techniques. J Comput Assist Tomogr 14:581–589

    Google Scholar 

  26. Van den Brekel MWM, Castelijns JA, Croll GA, Stel HV, Valk J, Waal I van der, Golding FR, Meijer CJLM, Snow GB (1991) Magnetic resonance imaging vs palpation of cervical lymph node metastasis. Arch Otolaryngol Head Neck Surg 117:666–673

    Google Scholar 

  27. Van den Brekel MWM, Castelijns JA, Stel HV, Golding RP, Meijer CJLM, Snow GB (1993) Modern imaging techniques and ultrasound guided aspiration cytology for the assessment of the neck node metastases: a prospective comparative study. Eur Arch Otorhinolaryngol 250:11–17

    Google Scholar 

  28. Van Dongen GAMS, Leverstein H, Roos JC, Quak JJ, Brekel MWM van den, Lingen A van, Martens HJM, Castelijns JA, Visser GWM, Meijer CJLM, Teule GJJ, Snow GB (1992) Radioimmunoscintigraphy of head and neck cancer using 99Tclabeled monoclonal antibody E 48 F(ab′)2. Cancer Res 52: 2569–2574

    Google Scholar 

  29. Visser GWM, Gerretsen M, Herscheid JDM, Snow GB, Dongen GAMS van (1993) Labeling of monoclonal antibody E48 with 186Re using the MAG3 chelate for radioimmunotherapy of head and neck cancer. A technical protocol. J Nucl Med 34: 1953–1963

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Otolaryngology, Head and Neck Surgery, Free University Hospital, P.O. Box 7075, 1007 MB, Amsterdam, The Netherlands

    J. Quak & G. van Dongen

Authors
  1. J. Quak
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. G. van Dongen
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

Part of this research was supported by Centocor BV, Leiden, The Netherlands, the Dutch Ministry of Economic Affairs and the Dutch Cancer Foundation

Rights and permissions

Reprints and permissions

About this article

Cite this article

Quak, J., van Dongen, G. Current perspectives in the use of monoclonal antibodies for detection and treatment of head and neck tumors. Eur Arch Otorhinolaryngol 251, 1–5 (1994). https://doi.org/10.1007/BF00175949

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00175949

Key words

Search

Navigation